|
 |
| home > pmps > summer 2003 > highly purified water production by subsequent ultrafiltration - guaranteed integrity |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Depending on the quantities being produced, membrane methods for the production of water in water for injection (WFI) quality permit cost savings in the pharmaceutical industry by a factor of 5.5 to 7.5 compared with distillation. It is easier and thus far cheaper to produce highly purified water (HPW) by reverse osmosis combined with electro-deionisation and a second reverse osmosis or an ultrafiltration stage. HPW, a new water quality introduced in June 2002, is physically and chemically identical to WFI in accordance with the European Parliament. It is typically used for the final rinsing of primary packing materials and for the non-sterile manufacture of ointments, liquids and suppositories. WFI produced by distillation is still mandatory for injection and infusion solutions used throughout Europe.
A water treatment system with a second reverse osmosis stage used for the production of HPW has an extremely low cut-off rate (MWCO) of less than 100 Dalton and thus provides good protection against micro-organisms and pyrogens. However, since no method exists for testing the integrity of such membranes, it is not possible to achieve the validation generally demanded in the pharmaceutical industry with systems based on this process technology.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Dieter Schuster, Sales and Export Manager of Christ GmbH, Germany and Christ AG, Aesch/Switzerland, and Dr John Hutcheson, Senior Manager with Christ-Kennicott Water Technology Ltd, UK
Dieter Schuster has worked for the Christ Water Technology Group since 1979. He is currently Sales and Export Manager in the Pharmaceuticals and Life Sciences Division of Christ GmbH, Germany and Christ AG, Aesch/Switzerland, both members of Austrian Best Water Technology Group (BWT).
Dieter specialises in all areas of pharmaceutical water treatment and holds a Diploma in Process Engineering.
Dr John Hutcheson is Senior Manager with Christ-Kennicott Water Technology Ltd, UK.
He has specialised in filtration technologies and water purification systems and has vast experience in pharma grade water treatment plants. He holds a PhD in Chemistry.
Before joining Christ he was General Manager of USF Ltd.
|
|
|
|
|
|
 |
Industry Events |
 |
P-MEC India
1-3 December 2010, Mumbai, India
Hosted alongside CPhI and ICSE, P-MEC (The Pharmaceutical Machinery and Equipment Convention) was first held in Madrid in 2005 and has since rapidly grown into a must-attend event for both sellers and buyers of pharmaceutical processing and manufacturing equipment. P-MECIndia was launched in 2007. P-MEC has proven to be an invaluable new opportunity for exhibitors to meet new and existing clients, to find and approach new markets and to stay abreast of new developments in pharmaceutical manufacturing.
More info >> |
|
 |
News and Press Releases |
 |
Ready-Made Ammonium Formate Buffer Simplifies Glycoprofiling
To add to their range of drug glycoprofiling products, Ludger Ltd now offer the LudgerSep™ x40 ammonium formate buffer concentrate for glycan amide HPLC (Cat No. LS-N-BUFFX40). Preparation of ammonium formate buffer is laborious and variations in buffer pH between batches can result in out of specification problems during glycan analysis. The new x40 concentrate makes preparation of clean, consistent ammonium formate buffer easy - simply dilute with water and use directly for elution gradients for glycan HPLC.
More info >> |
|
|
